In-house IP roundup – Generics say SPC Waiver will save money but increase litigation, counsel share M&A tips

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

In-house IP roundup – Generics say SPC Waiver will save money but increase litigation, counsel share M&A tips

SPC 168

Patent Strategy, a new service from Managing IP, rounds up the latest news and analysis from patent-focused businesses

SPC man

Generics: SPC Waiver will save money but increase litigation

Fresenius Kabi, Insud Pharma and other generic drug firms explain how the EU’s SPC manufacturing waiver in its compromised form will benefit them – but also how its notification clause could make litigation easier and more attractive to innovator drug companies. (Read more … )

chain

In-house counsel share M&A due diligence tips

Uber, Nestlé and a luggage company speak to Patent Strategy about their due diligence difficulties during mergers and acquisitions and how they avoid the inherent portfolio analysis pitfalls. (Read more … )

Sign up to receive more content like this in Patent Strategy’s weekly newsletter.

more from across site and SHARED ros bottom lb

More from across our site

In-house counsel explain why firms should provide risk management advice that helps them achieve their goals
Attorneys at four firms explain the AI trends they expect in the future, including a potential shift in who plaintiffs sue for copyright infringement
The dispute at the Intellectual Property Enterprise Court pits Dryrobe against D-Robe and will include a ‘genericide’ element
Novo Nordisk losing patent rights covering Ozempic in Canada and a US Supreme Court decision favouring Ed Sheeran were also among the top talking points
The court will hand down its ruling in Iconix v Dream Pairs on Tuesday, June 24, in a case that concerns post-sale confusion
Developments included a stay in a row concerning the UPC’s jurisdiction and a timeline for the rollout of the long-awaited new CMS
Jorg Thomaier, who has been head of IP at the German pharma company since 2010, will leave later this year and hand the reins to the company’s head of patents
Companies must conduct thorough IP due diligence – even if it may not be mandatory
Celia Cheah at Wong & Partners in Malaysia says she is aiming to tap into the Baker McKenzie member firm’s international network and expand its IP portfolio
A team of partners that joined Boies Schiller Flexner say they would like to double the firm’s patent litigation capabilities
Gift this article